Effects of modified biliopancreatic diversion on glucose tolerance of GK rats

Obesity Surgery

Volumn 23, Issue 4, 2013, Pages 522-530

  Weng, Shan Geng ^a   Zhang, Bin ^a   Feng, Su ^a   Xu, Chang Guo ^a   Lin, Chun Zhong ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

GK rats; Glucose tolerance; Hormones; Modified biliopancreatic diversion

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; LIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIDIABETIC ACTIVITY; ARTICLE; BILIOPANCREATIC BYPASS; BODY WEIGHT; CONTROLLED STUDY; DUODENAL JEJUNAL BYPASS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GOTO KAKIZAKI RAT; INSULIN BLOOD LEVEL; INTERMETHOD COMPARISON; LIPID BLOOD LEVEL; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; STOMACH BYPASS; TREATMENT OUTCOME;

ANIMALS; BILIOPANCREATIC DIVERSION; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DUODENUM; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; INSULIN; JEJUNUM; LIPIDS; MALE; RANDOM ALLOCATION; RATS; RATS, INBRED STRAINS;

EID: 84876471923     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-012-0830-x     Document Type: Article

References (12)

1. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-37.
2. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339-50.
3. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1-11.
4. Mason EE. Ilial transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg. 1999;9:223-8.
5. Patriti A, Aisa M, Annetti C, et al. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-Kakizaki rats through an enhanced proglucagon gene expression and L-cell number. Surgery. 2007;142(1):74-85.
6. Weng S-G. Modified biliopancreatic diversion for GK rats: a proposal for a simpler technique and mechanism research. Obes Surg. 2012;22(6):997-8.
7. Hanefeld M, Temelkova-Kurktschiev T. The postprandial state and the risk of atherosclerosis. Diabet Med. 1997;14 Suppl 3:S6-S11.
8. Coutinho M, et al. The relationship between glucose and incident cardiovascular events. Diabetes Care. 1999;22(2):223-40.
9. O'Keefe JH, Bell DS. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol. 2007;100(5):899-904.
10. Speck M, Cho YM, Rubino F, et al. Duodenal-jejunal bypass protects GK rats from beta-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells co-expressing GIP and GLP-1. Am J Physiol Endocrinol Metab. 2011;300(5):E923-32.
11. Maedler K, Spinas GA, Dyntar D, et al. Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes. 2001;50(1):69-76.
12. Listenberger LL, Ory DS, Schaffer JE. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem. 2001;276(18):14890-5.